Can Bill Gruber Take Solace Where He Took Interlace?
Jul 2, 2015
34:05
Episode Description
Solace Therapeutics CEO Bill Gruber hopes to repeat the successful exit he helped execute when Hologic paid close to $300 million for his previous company Interlace.
Proudly Supported by
Patrons of Health Podcast Library
Supporting Shows
